Treatment of Patients With Age-Related Macular Degeneration With Anecortave Acetate

NO_LONGER_AVAILABLE

Conditions studied: Macular Degeneration

In brief

The purpose of this study is to evaluate whether anecortave acetate can slow or stop the progression of age-related macular degeneration in patients who do not qualify for other studies and have no other treatment options.

Key facts

Study ID

NCT00349739

Run by

University of Iowa

Starts

2003-01-01

Expected to finish

2008-08-01

Last updated by the study team

2010-01-15

Who can join

Age: 55 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Choroidal neovascularization, mostly occult
• Visual acuity > 20/40 in study eye

You may not qualify if…

• Allergy to fluorescein dye
• Inability to stop warfarin prior to treatment
• Pregnancy
• Other serious ocular diseases or conditions

Where it is running

• University of Iowa Hospitals and Clinics, Ophthalmology — Iowa City, Iowa, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.